First Time in Human Study With GSK1325756
NCT01209052
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
58
Enrollment
INDUSTRY
Sponsor class
Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
DRUG:
GSK1325756
OTHER:
Placebo
Sponsor
GlaxoSmithKline